MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$422,741
Unit: Dollar
Positive Cash Flow Breakdown
Trade and other receivables
Proceeds from maturity of fixed ...
Allowances for expected credit l...
Others
Negative Cash Flow Breakdown
Net loss
Other assets
Recoveries for expected credit l...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
286,451
543,575
1,036,117
1,948,490
Amortization of operating lease rou assets
15,604
15,589
14,768
14,354
Amortization of finance lease rou assets
2,723
-
-
-
Allowances for expected credit losses
68,164
202,497
55,269
175,818
Recoveries for expected credit losses
-
26,743
49,855
0
Bad debts written off
-
-
0
-
Recoveries for expected credit losses
-118,126
-
-
-
Depreciation of property, plant and equipment
28,065
28,293
28,430
29,001
Dividend income
-
0
360
4,192
Fair value loss on investments in equity securities
-
0
-2,722
0
Loss arising from settlement of supplier contract dispute
-
-
0
0
Gain on disposal of investments in equity securities
-
-
-346
27,547
Loss on lease termination
-
-
0
0
Impairment on property
-
-
0
-
Dividend income
0
-
-
-
Share-based compensation
-
-
794,770
0
Fair value loss on investments in equity securities
0
-
-
-
Operating loss before working capital changes
-911,156
323,939
-190,027
-521,557
Inventories
33,360
-9,549
-330,745
-381,176
Trade and other receivables
553,575
-243,016
-944,701
161,860
Other assets
-249,999
-249,999
-
-
Trade and other payables
24,596
187,891
-156,034
-1,227,454
Advance payment from customer
-65
31
-2,879
-84
Operating lease liabilities
-16,026
-13,993
-7,700
-13,410
Tax liabilities
22
227
-42,256
19,473
Net cash used in operating activities
-422,491
-147,671
961,062
-1,237,465
Acquisition of investments in equity securities
-
-
95
9,064
Dividend income
0
0
360
21,752
Proceeds from maturity of fixed deposits
443,395
-
-
-
Change in fixed deposits placed with original maturities of more than three months
5,997
13,663
15,761
15,872
Payment for acquisition of right-of-use assets
21,008
-
-
-
Purchase of plant and equipment
250
325
977
5,483
Proceeds from disposal of investments in equity securities
-
-
10,756
1,020,873
Proceeds from settlement of supplier contract dispute
-
-
0
0
Net cash generated from/(used in) investing activities
416,140
-13,988
-5,717
994,646
Advance from/ (repayments to) directors
-5,584
80,717
-497
34,187
Repayment of finance lease liabilities
1,817
-
-
-
Cash paid for fractional shares in reverse stock split
0
-
270
0
Share subscription
-
-
267,311
-
Deposit payment of finance lease liabilities
-
21,008
-
-
Net cash generated from/(used in) financing activities
13,607
59,709
266,544
34,187
Foreign currency translation adjustment
-13,288
13,544
-92,598
28,535
Net change in cash and cash equivalents
-6,032
-88,406
1,129,291
-180,097
Cash and cash equivalents, beginning of financial period
2,397,977
2,486,383
1,357,092
2,886,966
Cash and cash equivalents, end of financial period
2,391,945
2,397,977
2,486,383
1,357,092
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturity of
fixed deposits
$443,395
something is missing
$21,008
Net cash generated
from/(used in) investing...
$416,140
(1041.96%↑ Y/Y)
Net cash generated
from/(used in) financing...
$13,607
(819.95%↑ Y/Y)
Canceled cashflow
$27,255
Canceled cashflow
$7,401
Net change in cash
and cash...
-$6,032
(99.55%↑ Y/Y)
Canceled cashflow
$429,747
Trade and other
receivables
$553,575
(50.29%↑ Y/Y)
something is missing
$143,202
Inventories
$33,360
(119.28%↑ Y/Y)
Trade and other
payables
$24,596
(121.85%↑ Y/Y)
Tax liabilities
$22
Payment for acquisition
of right-of-use...
$21,008
Change in fixed
deposits placed with...
$5,997
(-80.80%↓ Y/Y)
Purchase of plant and
equipment
$250
(-99.18%↓ Y/Y)
Advance from/
(repayments to) directors
-$5,584
(-303.18%↓ Y/Y)
Repayment of finance lease
liabilities
$1,817
Net cash used in
operating activities
-$422,491
(72.95%↑ Y/Y)
Canceled cashflow
$754,755
Foreign currency
translation adjustment
-$13,288
(-105.15%↓ Y/Y)
Allowances for expected
credit losses
$68,164
(69.88%↑ Y/Y)
Depreciation of property,
plant and equipment
$28,065
(-48.45%↓ Y/Y)
Amortization of operating
lease rou assets
$15,604
(-42.87%↓ Y/Y)
Amortization of finance lease
rou assets
$2,723
Operating loss before
working capital changes
-$911,156
(19.99%↑ Y/Y)
Canceled cashflow
$114,556
Other assets
-$249,999
Operating lease
liabilities
-$16,026
(-19.59%↓ Y/Y)
Advance payment from
customer
-$65
(99.92%↑ Y/Y)
something is missing
-$621,135
Net loss
$286,451
Recoveries for expected
credit losses
-$118,126
(-224.46%↓ Y/Y)
Buy us a coffee
BioNexus Gene Lab Corp (BGLC)
BioNexus Gene Lab Corp (BGLC)